Puma Biotechnology Stock (NASDAQ: PBYI) stock price, news, charts, stock research, profile.
Open | $3.70 |
Close | $3.95 |
Volume / Avg. | 335.40K / 462.43K |
Day Range | 3.70 - 3.98 |
52 Wk Range | 2.13 - 7.73 |
Market Cap | $203.45M |
P/E Ratio | 11.41 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 71 |
Short Interest | 7.18% |
Days to Cover | 2.82 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Puma Biotechnology (NASDAQ:PBYI) through any online brokerage.
Other companies in Puma Biotechnology’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Skye Bioscience (NASDAQ:SKYE), Innate Pharma (NASDAQ:IPHA), Adverum Biotechnologies (NASDAQ:ADVM) and Atossa Therapeutics (NASDAQ:ATOS).
There is no analysis for Puma Biotechnology.
Puma Biotechnology has a consensus price target of $7.00.
The stock price for Puma Biotechnology (NASDAQ: PBYI) is $4.2176 last updated July 16, 2024 at 7:12 PM EDT.
There are no upcoming dividends for Puma Biotechnology.
Puma Biotechnology’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Puma Biotechnology.
Puma Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.